Health Canada has approved the first test to detect antibodies specific to COVID-19 in the country.
The DiaSorin LIAISON was previously approved for use in the United States nearly three weeks ago.
Health Canada says serological testing will help determine if people who have been infected with COVID-19 are immune to the virus.
“Further research will also help us fully understand the relationship between positive antibody tests and protection against re-infection,” said the department in a release.
At least one million Canadian blood samples will be collected and tested over the next two years to track the virus, it said.
Health Canada has approved 17 other tests which are used to determine if a person has an active infection.
“Health Canada will continue to focus on the health and safety of Canadians while expediting supply of safe and effective health products related to COVID-19,” it said.
